NCT03063554

Brief Summary

This Endoscopic Ultrasound guided Biliary Drainage (EUS-BD) vs. Endoscopic Retrograde Cholangiopancreatography (ERCP-TP) trial (BILPAL) is a randomized controlled multicenter trial that will provide evidence whether or not traditional ERCP biliary drainage is to be performed in patients with obstruction in bile duct due to unresectable pancreatic head or periampullary tumor.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable pancreatic-cancer

Timeline
Completed

Started Oct 2016

Shorter than P25 for not_applicable pancreatic-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 18, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 24, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

February 24, 2017

Status Verified

February 1, 2017

Enrollment Period

1.9 years

First QC Date

February 16, 2017

Last Update Submit

February 20, 2017

Conditions

Keywords

EndoscopyPancreatic CancerBile ductPeriampullaryERCPBiliary drainageBiliary obstructionEUSBDTEUSEUSEndoscopic Ultrasound

Outcome Measures

Primary Outcomes (1)

  • Efficacy of Stent Patency

    Efficacy is measure by the evaluation of biliary stent patency at month 6 post randomization

    6 months after randomization

Secondary Outcomes (6)

  • Safety evaluation: Assessment of number and frequency of procedure related adverse events within 1 month of the procedure

    Within 1 month of procedure

  • Clinical Success

    1 month from procedure

  • Technical Success

    1 month from procedure

  • Survival duration

    2 years from randomization

  • Serum bilirubin decrease

    1 month from procedure

  • +1 more secondary outcomes

Study Arms (2)

Endoscopic Ultrasound Guided Biliary Drainage

ACTIVE COMPARATOR

Endoscopic Ultrasound Guided biliary drainage with stent placement. EUS via either stomach or duodenum.

Procedure: Endoscopic Ultrasound Guided Biliary Drainage

ERCP

PLACEBO COMPARATOR

Endoscopic Retrograde Cholangiopancreatography with transpapillary biliary stent placement only.

Procedure: ERCP

Interventions

Endoscopic Ultrasound Guided biliary drainage with stent placement;

Also known as: EUSBD
Endoscopic Ultrasound Guided Biliary Drainage
ERCPPROCEDURE

Endoscopic Retrograde Cholangiopancreatography with transpapillary biliary stent placement

Also known as: ERCP-TP
ERCP

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 90 years old
  • Clinically indicated for biliary endoscopic drainage with Endoscopic Ultrasound guidance or ERCP
  • CT scan has demonstrated a lesion in the pancreatic head area with metastases and/ or local tumor ingrowth preventing resection.
  • CT with evidence of distant metastases or local tumor ingrowth into portal or mesenteric vessels (as defined by the tumor surrounding the vessel for at least 180 degrees of the circumference)
  • A serum bilirubin level of \> 2.5mg/dL at randomization
  • Deemed surgically unresectable
  • Consents to participation in the randomized controlled trial

You may not qualify if:

  • \> 90 years
  • Severe comorbidity (Karnofsky \<50%)
  • Any prior successful previous biliary drainage including ERCP and stenting, percutaneous biliary and surgical,
  • Prior surgically altered pancreaticobiliary or gastroduodenal anatomy.
  • Female of childbearing potential with a positive pregnancy test prior to the procedure or intends to become pregnant during the study.
  • Currently participating in another device trial that has not completed the primary endpoint or that clinically interferes with the endpoints of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medical College

New York, New York, 10065, United States

RECRUITING

MeSH Terms

Conditions

Pancreatic NeoplasmsBiliary Tract Neoplasms

Interventions

Cholangiopancreatography, Endoscopic Retrograde

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesBiliary Tract Diseases

Intervention Hierarchy (Ancestors)

CholangiographyRadiography, AbdominalRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Digestive SystemEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Michel Kahaleh, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michel Kahaleh, MD

CONTACT

Monica R Gaidhane, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Endoscopy

Study Record Dates

First Submitted

February 16, 2017

First Posted

February 24, 2017

Study Start

October 18, 2016

Primary Completion

September 1, 2018

Study Completion

October 1, 2018

Last Updated

February 24, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

Locations